Several metabolic disorders, including type 2 diabetes and metabolic syndrome, are associated with chronic low-grade inflammation. This entails immune, vascular and nervous system dysfunction. Chronic inflammation plays a key role in the development of peripheral neuropathy, a progressive complication that affects the peripheral nervous and muscular systems.

Metabolic support, early identification, and control ‘as nature intended’ are crucial for preventing the progression of peripheral neuropathy and help improve the quality of life of patients with metabolic disorders.